3553-12-6

Basic information

• Product Name: 3-Acetylaminopyrazole
• Synonyms: 3-Acetylaminopyrazole;3-AcetaMidopyrazole;N-(1H-pyrazol-3-yl)acetamide
• CAS NO: 3553-12-6
• Molecular Formula: C₅H₇N₃O
• Molecular Weight: 125.12858
• Mol File: 3553-12-6.mol
• Article Data: 10

Chemical Properties

• Melting Point: 223-224 °C
• Boiling Point: 449.6°Cat760mmHg
• Flash Point: 225.7°C
• Appearance: /
• Density: 1.33g/cm³
• Vapor Pressure: 2.83E-08mmHg at 25°C
• Refractive Index: 1.62
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 12.32±0.10(Predicted)
• CAS DataBase Reference: 3-Acetylaminopyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Acetylaminopyrazole(3553-12-6)
• EPA Substance Registry System: 3-Acetylaminopyrazole(3553-12-6)

Safety Data

• Hazardous Substances Data: 3553-12-6(Hazardous Substances Data)

Usage

General Description

3-Acetylaminopyrazole is a chemical compound with the molecular formula C7H8N2O. It is a pyrazole derivative that is widely used in the pharmaceutical industry as a building block in the synthesis of various drugs and biologically active compounds. 3-Acetylaminopyrazole is known for its ability to act as a versatile intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. It is used as a reagent in organic synthesis and has been reported to exhibit antibacterial and antifungal activities. Additionally, 3-Acetylaminopyrazole is also used as a reagent in the preparation of pyrazole-based Schiff bases, which have potential applications in the field of medicinal chemistry.

InChI:InChI=1/C5H7N3O/c1-4(9)7-5-2-3-6-8-5/h2-3H,1H3,(H2,6,7,8,9)

Upstream product

• 90000-72-9 N-(2-acetyl-2H-pyrazol-3-yl)-acetamide 
• 75-36-5 acetyl chloride 
• 1225387-53-0 3⁽⁵⁾-aminopyrazole 
• 108-24-7 acetic anhydride 
• 72159-21-8 N-(1-benzyl-1H-pyrazol-3-yl)-acetamide 
• 1820-80-0 3-aminopyrazole 

Downstream Products

• 131319-56-7 1-(m-nitrophenyl)-3-acetamidopyrazole 
• 131319-52-3 1-(o-nitrophenyl)-3-acetamidopyrazole 
• 154366-45-7 3-Acetylamino-1-methylcarbamoyl-pyrazol 
• 131319-57-8 1-(p-nitrophenyl)-3-acetamidopyrazole 
• 141853-26-1 3-Acetamido-1-methyl-4-nitropyrazole 
• 16461-96-4 N-(4-nitro-1⁽²⁾H-pyrazol-3-yl)-acetamide 
• 786700-23-0 N-(1-{6-methyl-1-[2-methyl-4-(methyloxy)phenyl]-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl}-1H-pyrazol-3-yl)acetamide 
• 1251929-61-9 N-{1-[(2-fluorophenyl)methyl]-1H-pyrazol-3-yl}acetamide 
• 1251929-60-8 N-{1-[(2,6-difluorophenyl)methyl]-1H-pyrazol-3-yl}acetamide 
• 909861-89-8 N-{1-[(2-chloro-6-fluorophenyl)methyl]-1H-pyrazol-3-yl}acetamide 
• 1372891-59-2 C₁₁H₁₂N₄O 
• 1606126-38-8 N-(4-(phenylethynyl)-1H-pyrazol-5-yl)acetamide 
• 1251929-58-4 C₁₂H₁₁ClFN₃O 

Relevant articles and documents

TREATMENT OF CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES

The present disclosure relates to methods for the treatment or prevention of cancer, an inflammatory disease or an autoimmune disease with compounds of the invention as disclosed herein. The present disclosure also relates to methods for reducing risk of developing cancer, an inflammatory disease or an autoimmune disease with compounds of the invention as disclosed herein.

Deuterated pyrrolidone derivative Pharmaceutical compositions and uses thereof

The invention relates to a deuterated pyrrolidone derivative and a preparation method thereof, and also relates to application of the deuterated pyrrolidone derivative and a pharmaceutical composition thereof in treatment and prevention of metabolic disorder related diseases, and belongs to the field of medicines.

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic retinal degenerations, age-related macular degeneration and Usher Syndrome, and hearing loss associated with Usher Syndrome are described herein.